VTRNA2-1 and neoplasm: Elevated expression of nc886 in tumors was correlated with the number of primary tumors (p=0.028, Table 1), tumor aggressiveness (see T staging in Figure 1B, p for trend=0.050) and metastasis to lymph nodes (p=0.028, Figure 1C).